Diskussionsleiter: L. Fabritz (Birmingham, UK), S. Klaassen (Berlin)
| (P170) | Soluble adenylyl cyclase affects AKT and CaMKII activity in adult rat cardiomyocytes, but not in H9c2 cells. Are H9c2 cells really cardiomyocytelike? | |
| N. Radev, T. Poppenga, A. Al Haj, H. G. Mannherz, A. Mügge, N. Hamdani, D. Cimiotti, K. Jaquet, für die Studiengruppe: AG13 (Bochum) | ||
| (P171) |
DGK-Abstract-Preis 2021: |
|
| R. Chen, G. Grüner, A. P. Arias Loza, M. Kohlhaas, A. Nickel, N. Abdelfatah, T. Williams, C. Maack, B. Gerull (Würzburg, 97078; Calgary, CA) | ||
| (P172) | In-vitro cardiomyocyte differentiation of mouse embryonic stem cells with patient specific LMNA mutation reveals dysregulation of mTOR pathway | |
| B. Neupane, K. Pradhan, M. Gramlich (Aachen) | ||
| (P173) | Expression of the TMEM43 Mutation p.S358L in a Transgenic Zebrafish Model Reveals Alterations in Cardiac Morphology and Performance | |
| M. Zink, A. Seewald, M. C. Nguyen, T. Williams, D. Liedtke, C. Stigloher, S. J. Childs, B. Gerull (Würzburg; Calgary, CA) | ||
| (P174) | Mechano-energetic uncoupling underlies lack of inotropic reserve in Barth syndrome cardiomyopathy | |
| J. Schwemmlein, A. Nickel, M. Kohlhaas, M. Hohl, E. Bertero, V. Sequeira, C. Krug, C. Carlein, K. Münker, S. Atighetchi, A. Müller, A. Kazakov, R. Kappl, K. von der Malsburg, M. Böhm, U. Laufs, P. Rehling, J. Dudek, M. van der Laan, L. Prates-Roma, C. Maack (Würzburg, Homburg/Saar, Saarbrücken, Leipzig, Göttingen) | ||
| (P175) | The RBM20 splicing target CAMK2D causes cardiac dysfunction in RBM20 cardiomyopathy | |
| M. van den Hoogenhof, M. Dewenter, J. Duran, D. Lennermann, M. Krüger, E. Creemers, J. Backs (Heidelberg, Köln; Amsterdam, NL) | ||
| (P176) | A novel "loss of function" Myoscape mutation derived from patients with Dilated Cardiomyopathy and Short-QT syndrome affects cardiac output in zebrafish in vivo and hypertrophic gene program in vitro | |
| B. Völschow, A. Farahvashi, M. Leye, C. Tannert, P. Doldi, N. Frey, M. Eden (Kiel, München, Heidelberg) | ||
| (P177) | Decoding dilated cardiomyopathy with ataxia (DCMA) using patient-derived and gene-edited human induced pluripotent stem cell (iPSC)-derived cardiomyocytes | |
| A. Janz, A. Cirnu, M. Leskien, A. Seewald, Y. Ueda, M. Regensburger, M. Kohlhaas, N. Nose, P. Wörsdörfer, N. Wagner, E. Klopocki, T. Higuchi, H. Duff, C. Maack, S. Ergün, B. Gerull (Würzburg; Calgary, CA) | ||
| (P178) | Characterization of gender differences in a mouse model of Rbm20 cardiomyopathy | |
| D. Lennermann, M. van den Hoogenhof, M. Dewenter, C. Sticht, M. Krüger, J. Backs (Heidelberg, Mannheim, Köln) | ||
| (P179) | LXR activation alters the cardiac lipid profile and reduces cardiac damage in an isoproterenol-induced cardiomyopathy model | |
| D. Ritter, A. Thiele, A. Blumrich, N. Beyhoff, K. Lüttges, E. Smeir, J. Kasch, J. Grune, O. J. Müller, R. Klopfleisch, C. Jäger, A. Foryst-Ludwig, U. Kintscher (Berlin, Kiel) |